Hemoglobin-based oxygen carriers in trauma care: Scientific rationale for the US multicenter prehosptial trial

World Journal of Surgery

Volumn 30, Issue 7, 2006, Pages 1247-1257

  Moore, Ernest E ^a,b   Cheng, Aaron M ^a,b   Moore, Hunter B ^a,b   Masuno, Tomohiko ^a,b   Johnson, Jeffrey L ^a,b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; POLYMERIZED HEMOGLOBIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLOGRAFT; ARTICLE; BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYSTALLOID; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HUMAN; INJURY; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE ORGAN FAILURE; OXYGENATION; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SYSTOLIC BLOOD PRESSURE; TRAUMATOLOGY; UNITED STATES;

BLOOD SUBSTITUTES; BLOOD TRANSFUSION; EMERGENCY MEDICAL SERVICES; ERYTHROCYTES; HEMOGLOBINS; HUMANS; INJURY SEVERITY SCORE; POLYMERS; RESUSCITATION; SHOCK, HEMORRHAGIC; UNITED STATES;

EID: 33746085975     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0499-6     Document Type: Article

References (58)

1. Department of Health and Human Services: 21 CFR601.25(d) (2).
2. Center for Biologics Evaluation and ResearchPoints to consider in the safety evaluation of hemoglobin-based oxygen carriers. Transfusion 1991;31:369-371.
3. Alayash AI. Oxygen therapeutics - Can we tame hemoglobin? Nat Rev Drug Discov. 2004;3:152-159.
4. Creteur J, Sibbald W, Vincent JL. Hemoglobin solutions - Not just red blood cell substitutes. Crit care Med 2000;28:3025-3034.
5. McFaul SJ, Bowman PD, Villa VM. Hemoglobin stimulates the release of proinflammatory cytokines from leukocytes in whole blood. J Lab Clin Med 2000;135:263-269.
6. Winslow RM. Current status of blood substitute research - towards a new paradigm. J Intern Med 2003;253: 508-517.
7. Center for Biologics Evaluation and ResearchPoints to consider on efficacy evaluation of Hemoglobin and perfluorocarbon based oxygen carriers. Transfusion 1994;34: 712-713.
8. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock - A randomized controlled efficacy trial. JAMA 1999;282:1857-1864.
9. Hess JR, MacDonald VW, Brinkley WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993;74:1769-1778.
10. Poli de Figueiredo LF, Mathru M, et al. Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes. J Trauma 1997;42:847-856.
11. Gulati A, Sen AP, Sharma Ac, et al. Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat. Am J Physiol 1997;273:H827-H836.
12. Schultz SC, Grady B, Cole F, et al. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993;122:301-308.
13. Rohlfs RJ, Bruner E, Chiu A, et al. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 1998;273:12128-12134.
14. Boura C, Caron A, Longrois D, et al. Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance. Shock 2003;19:176-182.
15. Wettstein R, Cabrales P, Erni D, et al. Resuscitation from hemorrhagic shock with MalPEG-albumin: comparison with MalPEG-hemoglobin. Shock 2004;22:351-357.
16. Fushitan K, Imai K, Riggs AF. Oxygen properties of hemoglobin form the earthworm Lumbricus terrestric. J Biol Chem 1986;261:8414-8423.
17. Hirsch RE, Jelicks LA, Wittenberg BA, et al. A first evaluation of the natural high molecular weight polymeric lumbricus terrestric hemoglobin as an oxygen carrier. Art Cells Blood Subs Immob Biotech 1997;25:429-444.
18. Levy JH, Goodnough LT, Greilich PE, et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002;124:35-42.
19. LaMuraglia GM, O'Hara PJ, Baker WH, et al. The reduction of the allogenic transfusion requirement in aortic surgery with hemoglobin-based solution. J Vasc Surg 2000;31:299-308.
20. Standl T, Burmeister MA, Horn EP, et al. Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br J Anaesth 1998; 80:189-194.
21. Kasper SM, Walter M, Grune F, et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996;83:921-927.
22. Hughes GS Jr, Antal EJ, Locker PK, et al. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 1996;24:756-764.
23. Handrigan MT, Bentley TB, Oliver JD, et al. Choice of fluid influences outcome in prolonged hypotensive resuscitation after hemorrhage in awake rats. Shock 2005;23: 337-343.
24. Manning JE, Katz LM, Brownstein MR, et al. Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Shock 2000;13:152-159.
25. McNeil JD, Smith DL, Jenkins DH, et al. Hypotensive resuscitation using an polymerized bovine-based oxygen carrying solution leads to reversal of anaerobic metabolism. J Trauma 2001;50:1063-1075.
26. Gould SA, Moore EE, Moore FA, et al. Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery. J Trauma 1997;43:325-332.
27. Johnson JL, Moore EE, Offner PJ, et al. Resuscitation of the injured patient with polymerized stroma-free hemoglobin does not produce systemic or pulmonary hypertension. Am J Surg 1998;176:612-617.
28. Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998;187:113-122.
29. Botha AJ, Moore FA, Moore EE, et al. Postinjury neutrophil priming and activation - An early vulnerable window. Surgery 1995;118:35-365.
30. Ciesla DJ, Moore EE, Johnson JL, et al. A 12 year prospective study of postinjury multiple organ failure. Arch Surg 2005:140:432-440.
31. Aiboshi J, Moore EE, Ciesla DJ, et al. Blood transfusion and the two-insult model of postinjury multiple organ failure. Shock 2001;15:302-306.
32. Silliman CC, Moore EE, Johnson JL, et al. Transfusion of the injured patient: proceed with caution. Shock 2004;21:291-299.
33. Moore EE, Moore FA, Harken HA. et al. The two-event construct of postinjury multiple organ failure. Shock (in press).
34. Ingraham LM, Allen JM, Higgins CP, et al. Metabolic membrane and functional responses of human polymorphonuclear leukocytes to platelet activating factor. Blood 1982;59:1259-1266.
35. Sauaia A, Moore FA, Moore EE, et al. Early predictors of post-injury multiple organ failure. Arch Surg 1994;129: 38-45.
36. Moore FA, Moore EE, Sauaia A. Blood transfusion - An independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132:620-625.
37. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for post-injury multiple organ failure. Am J Surg 1999;178:570-572.
38. Biffl WL, Moore EE, Zallen G, et al. Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure. Surgery 1999;126: 198-202.
39. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-1721.
40. Nielsen HJ, Reimert CM, Pedersen AM, et al. Time-dependent spontaneous release of white cell and platelet derived bioactive substances from stored human blood. Transfusion 1996;36:960-965.
41. Shanwell A, Dristiansson M, Remberger M, et al. Generation of cytokines in red cell concentrates during storage is prevented by pre-storage white cell reduction. Transfusion 1997;36:678-684.
42. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury. Transfusion 1997;37:719-726.
43. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998;101:1458-1467.
44. Biffl WL, Moore EE, Offner PJ, et al. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity-abrogation by post storage washing but not prestorage leukoreduction. J Trauma 2001;50:426-432.
45. Moore EE. Blood substitutes: the future is now. J Am Coll Surg 2003;196:1-17.
46. Partrick DA, Moore EE, Barnett CC, et al. Human polymerized hemoglobin as a blood substitute avoids transfusion-induced PMN priming for superoxide and elastase release. Shock 1997;7:24.
47. Masuno T, Moore EE, Cheng AM, et al. Prehospital hemoglobin based oxygen carrier (HBOC) resuscitation presents acute lung injury. Surgery (in press).
48. Johnson JL, Moore EE, Offner PJ, et al. Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function. J Trauma 2004;50:449-456.
49. Huston P, Peterson R. Withholding proven treatment in clinical research. N Engl J Med 2001;345:912-913.
50. McRae AD, Weijer C. Lessons from everyday lives-amoral justification for acute care research. Crit Care Med 2002;30:1146-1151.
51. Gould SA, Moore EE, Hoyt DB, et al. The life-sustaining capacity of human polymerized hemoglobin when red cells may be available. J Am Coll Surg 2002;195:445-455.
52. Gawande A. Casualties of war-military care for the wounded from Iraq and Afghanistan. N Eng J Med 2004;351:2471-2478.
53. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:2206-1109.
54. Sandeen JL, Coopes VG, Holcomb JB. Blood pressure at which rebleeding occurs after resuscitation in swine and aortic injury. J Trauma 2004;54:5440-5117.
55. Claridge JA, Schulman AM, Young JS. Improved resuscitation minimizes respiratory dysfunction and blunts interleukin - 6 and nuclear factor - kB activation after traumatic shock. Crit Care Med 2002;30:1815-1819.
56. Dunham CM, Siegel JH, Weitreter L, et al. Oxygen debt and metabolic academia as quantitative predictors of mortality and severity of the ischemic insult in hemorrhagic shock. Crit Care Med 1991;19:231-241.
57. Shoemaker WC, Appel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 1988;16:1117-1120.
58. Department of Health and Human Services. 21 CFR 50.24.